236 related articles for article (PubMed ID: 34643048)
1. Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis through a Grade Analysis of Evidence.
Tian A; Jia H; Zhu S; Lu B; Li Y; Ma J; Ma X
Orthop Surg; 2021 Oct; 13(7):1941-1950. PubMed ID: 34643048
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
3. Romosozumab in postmenopausal women with low bone mineral density.
McClung MR; Grauer A; Boonen S; Bolognese MA; Brown JP; Diez-Perez A; Langdahl BL; Reginster JY; Zanchetta JR; Wasserman SM; Katz L; Maddox J; Yang YC; Libanati C; Bone HG
N Engl J Med; 2014 Jan; 370(5):412-20. PubMed ID: 24382002
[TBL] [Abstract][Full Text] [Related]
4. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
Singh S; Dutta S; Khasbage S; Kumar T; Sachin J; Sharma J; Varthya SB
Osteoporos Int; 2022 Jan; 33(1):1-12. PubMed ID: 34432115
[TBL] [Abstract][Full Text] [Related]
7. Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass.
Keaveny TM; Crittenden DB; Bolognese MA; Genant HK; Engelke K; Oliveri B; Brown JP; Langdahl BL; Yan C; Grauer A; Libanati C
J Bone Miner Res; 2017 Sep; 32(9):1956-1962. PubMed ID: 28543940
[TBL] [Abstract][Full Text] [Related]
8. Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials.
Liu Y; Cao Y; Zhang S; Zhang W; Zhang B; Tang Q; Li Z; Wu J
Climacteric; 2018 Apr; 21(2):189-195. PubMed ID: 29424257
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials (CDM-J).
Huang W; Nagao M; Yonemoto N; Guo S; Tanigawa T; Nishizaki Y
Pharmacoepidemiol Drug Saf; 2023 Jun; 32(6):671-684. PubMed ID: 36703260
[TBL] [Abstract][Full Text] [Related]
10. Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
Kobayakawa T; Miyazaki A; Saito M; Suzuki T; Takahashi J; Nakamura Y
Sci Rep; 2021 Jun; 11(1):11801. PubMed ID: 34083636
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis.
Kaveh S; Hosseinifard H; Ghadimi N; Vojdanian M; Aryankhesal A
Clin Rheumatol; 2020 Nov; 39(11):3261-3276. PubMed ID: 32385757
[TBL] [Abstract][Full Text] [Related]
12. Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials.
Wang WY; Chen LH; Ma WJ; You RX
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8253-8268. PubMed ID: 37750653
[TBL] [Abstract][Full Text] [Related]
13. Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial.
Takada J; Dinavahi R; Miyauchi A; Hamaya E; Hirama T; Libanati C; Nakamura Y; Milmont CE; Grauer A
J Bone Miner Metab; 2020 May; 38(3):310-315. PubMed ID: 31707465
[TBL] [Abstract][Full Text] [Related]
14. Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials.
Wang YK; Qin SQ; Ma T; Song W; Jiang RQ; Guo JB; Li K; Zhang YM
Medicine (Baltimore); 2017 May; 96(21):e6970. PubMed ID: 28538396
[TBL] [Abstract][Full Text] [Related]
15. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
16. Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
Miyauchi A; Dinavahi RV; Crittenden DB; Yang W; Maddox JC; Hamaya E; Nakamura Y; Libanati C; Grauer A; Shimauchi J
Arch Osteoporos; 2019 Jun; 14(1):59. PubMed ID: 31168657
[TBL] [Abstract][Full Text] [Related]
17. Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis.
Yuan F; Peng W; Yang C; Zheng J
Int J Surg; 2019 Jun; 66():1-11. PubMed ID: 30890377
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
19. Romosozumab: A Review in Postmenopausal Osteoporosis.
Paik J; Scott LJ
Drugs Aging; 2020 Nov; 37(11):845-855. PubMed ID: 32909197
[TBL] [Abstract][Full Text] [Related]
20. Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis.
Fan G; Zhao Q; Lu P; Chen H; Tan W; Guo W; Liu C; Liu J
Medicine (Baltimore); 2020 Apr; 99(15):e18964. PubMed ID: 32282692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]